Edesa Biotech Inc (EDSA)
4.52
+0.04
(+0.89%)
USD |
NASDAQ |
May 07, 16:00
4.52
0.00 (0.00%)
Pre-Market: 20:00
Edesa Biotech Cash from Operations (Quarterly): -1.406M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.406M |
| September 30, 2023 | -1.468M |
| June 30, 2023 | -1.805M |
| March 31, 2023 | -1.572M |
| December 31, 2022 | -1.791M |
| September 30, 2022 | -5.628M |
| June 30, 2022 | -3.027M |
| March 31, 2022 | -0.4167M |
| December 31, 2021 | -3.208M |
| September 30, 2021 | -0.3553M |
| June 30, 2021 | -3.120M |
| March 31, 2021 | -7.180M |
| December 31, 2020 | -3.010M |
| September 30, 2020 | -1.673M |
| June 30, 2020 | -1.353M |
| March 31, 2020 | -1.170M |
| December 31, 2019 | -0.7897M |
| March 31, 2019 | -1.225M |
| December 31, 2018 | -1.309M |
| September 30, 2018 | -0.9712M |
| June 30, 2018 | -1.111M |
| March 31, 2018 | -1.388M |
| December 31, 2017 | -1.144M |
| September 30, 2017 | -1.117M |
| June 30, 2017 | -0.9413M |
| Date | Value |
|---|---|
| March 31, 2017 | -1.276M |
| December 31, 2016 | -1.365M |
| September 30, 2016 | -1.192M |
| June 30, 2016 | -1.066M |
| March 31, 2016 | -1.073M |
| December 31, 2015 | -1.174M |
| September 30, 2015 | -0.9151M |
| June 30, 2015 | -0.9158M |
| March 31, 2015 | -1.296M |
| December 31, 2014 | -1.286M |
| August 31, 2014 | -0.8166M |
| May 31, 2014 | -1.034M |
| February 28, 2014 | -1.229M |
| November 30, 2013 | -1.187M |
| August 31, 2013 | -0.5588M |
| May 31, 2013 | -0.7262M |
| February 28, 2013 | -0.7888M |
| November 30, 2012 | -0.722M |
| August 31, 2012 | -0.9245M |
| May 31, 2012 | -1.004M |
| February 29, 2012 | -1.128M |
| November 30, 2011 | -0.8909M |
| August 31, 2011 | -0.9083M |
| May 31, 2011 | -0.9906M |
| February 28, 2011 | -0.6389M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-7.180M
Minimum
Mar 2021
-0.3553M
Maximum
Sep 2021
-2.293M
Average
-1.673M
Median
Sep 2020
Cash from Operations (Quarterly) Benchmarks
| Acasti Pharma Inc | -1.892M |
| Aurinia Pharmaceuticals Inc | 14.31M |
| Lexaria Bioscience Corp | -0.6196M |
| Xenon Pharmaceuticals Inc | -35.46M |
| ESSA Pharma Inc | -6.787M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.3057M |
| Free Cash Flow | -6.252M |
| Free Cash Flow Per Share (Quarterly) | -0.4497 |
| Free Cash Flow Yield | -46.15% |